The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication in vitro and decreases viral titers and disease progression in Syrian hamsters
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
1 March 2022
|
| In: |
mBio
Year: 2022, Volume: 13, Issue: 2, Pages: 1-23 |
| ISSN: | 2150-7511 |
| DOI: | 10.1128/mbio.03705-21 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1128/mbio.03705-21 Verlag, lizenzpflichtig, Volltext: https://journals.asm.org/doi/10.1128/mbio.03705-21 |
| Author Notes: | Iart Luca Shytaj, Mohamed Fares, Lara Gallucci, Bojana Lucic, Mahmoud M. Tolba, Liv Zimmermann, Julia M. Adler, Na Xing, Judith Bushe, Achim D. Gruber, Ina Ambiel, Ahmed Taha Ayoub, Mirko Cortese, Christopher J. Neufeldt, Bettina Stolp, Mohamed Hossam Sobhy, Moustafa Fathy, Min Zhao, Vibor Laketa, Ricardo Sobhie Diaz, Richard E. Sutton, Petr Chlanda, Steeve Boulant, Ralf Bartenschlager, Megan L. Stanifer, Oliver T. Fackler, Jakob Trimpert, Andrea Savarino, Marina Lusic |
| Item Description: | Gesehen am 31.05.2022 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 2150-7511 |
| DOI: | 10.1128/mbio.03705-21 |